Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
486427-17-2
is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin
2-(HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS
Smiles: CN(C1C=CC(=CC=1)NC(=O)NC1C=CC(=CC=1)OC(F)(F)F)C1=CC=NC(NC2C=C(C=CC=2)S(N)(=O)=O)=N1
whereas the response to VU-0357121 is not altered by the F585I/rmGlu5 mutation
MK 2206 Size:Solid 10 mg 486427-17-2MK2206 is a Akt inhibitor, is also an orally bioavailable allosteric inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non ATP competitive manner, which may result in the inhibition of the PI3K Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Product information CAS Number:
US$ 125.00
US$ 112.00
US$ 184.39
US$ 124.78
US$ 154.13
US$ 128.89
US$ 76.06
US$ 150.00
US$ 59.00